[{"Assets_0_Q3_USD":33977000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q3_USD":0.39,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.17,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.52,"EarningsPerShareBasic_3_Q3_USD":2.02,"EarningsPerShareDiluted_1_Q3_USD":0.51,"EarningsPerShareDiluted_3_Q3_USD":2.02,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4158000000.0,"NetIncomeLossConverted_1_Q3_USD":845000000.0,"NetIncomeLossConverted_3_Q3_USD":3335000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q3_USD":5254000000.0,"RevenuesConverted_3_Q3_USD":15327000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":14914000000.0,"StockholdersEquity_0_Q3_USD":14783000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1645000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1655000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1639000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1648000000.0,"filed":"20171026","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2017.0","name":"BRISTOL MYERS SQUIBB CO","period":"20170930","qtrs":"0","uom":"USD"}]